期刊文献+

大段同种异体骨移植术在胫骨中段骨肉瘤保肢中的应用 被引量:5

Reconstruction with massive allograft bone for osteosarcoma of the middle tibia with limb salvage
下载PDF
导出
摘要 背景:胫骨中段骨肉瘤患者的保肢手术并发症多,其保肢手术方案是当前临床治疗中的难点之一。目的:回顾性分析接受大段同种异体骨移植治疗的胫骨中段骨肉瘤病例,评估其综合临床疗效。方法:7例胫骨中段骨肉瘤患者,完成同种异体骨移植前正规辅助化疗方案,并移植前确认无远处转移。7例患者均接受大段同种异体骨移植+内固定术治疗,异体骨平均长度12.5 cm,移植中全部行腓肠肌肌瓣转移覆盖移植骨。移植后5例患者完成化疗方案,2例部分完成化疗方案。结果与结论:随访时间18-36个月。移植后1年局部复发1例,行截肢术后出现肺转移死亡;移植后1.5年肺转移1例,转移灶切除后存活;移植后2年死于肺转移1例;余4例无瘤生存。MSTS评分:平均26.5分。ISOLS评分:平均31分。4例未成年患者中,1例患者出现双下肢不等长畸形,患肢缩短2 cm。无移植后感染病例和移植后病理性骨折病例。结果提示,严格把握适应证的前提下,使用大段同种异体骨移植治疗胫骨中段骨肉瘤能够获得较好的移植后功能;移植中行腓肠肌肌瓣转移覆盖移植骨是降低移植后并发症的有效措施。 BACKGROUND:There are many complications of limb salvage surgery in patients with osteosarcoma of the middle tibia, and the limb salvage surgery is one of the current difficulties in clinical treatment. OBJECTIVE:To evaluate the clinical efficacy of reconstruction with massive al ograft bone for osteosarcoma of the middle tibia by retrospectively reviewing relevant cases. METHODS:Seven patients with osteosarcoma of the middle tibia were treated. And we analyzed their clinical data retrospectively. Al patients completed the formal preoperative adjuvant chemotherapy and we confirmed that there was no distant metastasis before surgery. Al patients received large al ogeneic bone transplantation and internal fixation, and the gastrocnemius muscle flap coveraged graft bone in surgery. The average length of al ogeneic bone was 12.5 cm. Five patients received postoperative adjuvant chemotherapy completely, and two patients received partly. RESULTS AND CONCLUSION:The fol ow-up period was 18-36 months. One patient had local tumor recurrence at 1 year after transplantation, and died of lung metastases after amputation. One patient survived after resection of lung metastases that occurred at 1.5 years after transplantation. One patient died of lung metastases at 2 years after transplantation. The rest four patients were tumor-free. The mean Musculoskeletal Tumor Society (MSTS) score was 26.5, the mean International Society of Limb Salvage (ISOLS) graft score was 31. Among four underage patients, one had leg length deformities, with limb shortening 2 cm. There were no postoperative infections and pathological fractures. Using large al ogeneic bone for the repair of bone defects after tumor surgery of the middle tibia can have a good clinical efficacy under the premise of strict indications. Using gastrocnemius muscle flap to cover the bone graft during surgery is an effective measure to reduce postoperative complications.
出处 《中国组织工程研究》 CAS CSCD 2014年第39期6381-6385,共5页 Chinese Journal of Tissue Engineering Research
关键词 生物材料 骨生物材料 胫骨 骨肉瘤 同种异体骨 tibia osteosarcoma transplantation, homologous
  • 相关文献

参考文献26

  • 1Allison DC, Carney SC, Ahlmann ER, et al.A mete-analysis of osteosarcoma outcomes in the modern medical era.Sarcoma. 2012;2012: 704872. 被引量:1
  • 2Hegyi M, Semsei AF, Jakab Z, et el. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer.2011 ;57(3): 415-422. 被引量:1
  • 3Mangat KS, Jeys LM, Carter SR. Latest developments in limb-salvage surgery in osteosarcoma.Expert Rev Anticancer Ther.2011;11(2): 205-215. 被引量:1
  • 4Tan PX, Yong BC, Wang J, et al. Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee.Eur J Surg Oncol. 2012;38(12):1171-1177. 被引量:1
  • 5Jeon DG, Kim MS, Cho WH, et al. Pasteurized autograft for intercalary reconstruction: an alternative to allograft.Clin Orthop Relat Res.2007;456: 203-210. 被引量:1
  • 6Poffyn B, Sys G, Mulliez A, et al. Extracorporeally irradiated autografts for the treatment of bone tumours: tips and tricks. Int Orthop.2011 ;35(6): 889-895. 被引量:1
  • 7Noguchi M, Mizobuchi H, Kawasaki M, et al. An intramedullary free vascularized fibular graft combined with pasteurized autologous bone graft in leg reconstruction for patients with osteosarcoma.J Reconstr Microsurg. 2008;24(7): 525-530. 被引量:1
  • 8Nonati D, Di Liddo M, Zavatta M, et el. Massive bone allograft reconstruction in high-grade osteosarcoma.Clin Orthop Relat Res. 2000;(377):186-194. 被引量:1
  • 9Ramseier L E, Malinin T I, Temple H T, et al. AIIograft reconstruction for bone sarcoma of the tibia in the growing child. J Bone Joint Surg Br. 2006;88(1): 95-99. 被引量:1
  • 10牛晓辉,黄真.骨肉瘤的规范化疗[J].中国肿瘤临床,2010,37(24):1390-1392. 被引量:6

二级参考文献37

  • 1吴兴,陈峥嵘,张光健.骨肉瘤保肢手术方法的初步评价[J].中国肿瘤临床,2004,31(15):874-877. 被引量:4
  • 2沈靖南,韩士英,董纲,李佛保,黄承达,丘钜世.膝部骨关节肿瘤及瘤样病变607例分析[J].中华骨科杂志,1995,15(12):814-817. 被引量:12
  • 3夏精武,邹云文,乐兴祥,季爱玉.四肢恶性肿瘤的保留肢体手术治疗[J].中国修复重建外科杂志,1995,9(4):215-218. 被引量:11
  • 4牛晓辉,蔡槱伯,张清,郝林,丁易.ⅡB期肢体骨肉瘤189例综合治疗临床分析[J].中华外科杂志,2005,43(24):1576-1579. 被引量:41
  • 5Bacci G,Longhi A,Fagioli F,et al.Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities:27 year experience at Rizzoli Institute,Italy[J].Eur J Cancer,2005,41(18):2836-2845. 被引量:1
  • 6Eliber F,Giuliano A,Eckardt J,et al.Adjuvant chemotherapy for ostesosarcoma:a randomized prospective trial[J].J Clin Oncol,1987,5(1):21-26. 被引量:1
  • 7Meyers PA,Schwartz CL,Krailo MD,et al.Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overall survival:a report from the Children's Oncology Group[J].J Clin Oncol,2008,26(4):633-638. 被引量:1
  • 8Longhi A,Ferrari S,Bacci G,et al.Long-erm follow-p of patients with doxorubicin-nduced cardiac toxicity after chemotherapy for osteosarcoma[J].Anticancer Drugs,2007,18(6):737-744. 被引量:1
  • 9Lewis IJ,Nooij MA,Whelan J,et al.Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy:a randomized phase III trial of the European Osteosarcoma Intergroup[J].J Natl Cancer Inst,2007,99(2):112-128. 被引量:1
  • 10Goorin AM,Schwartzentruber DJ,Devidas M,et al.Presurgical chemotherapy compared with immediate surgery and adjuvant che-motherapy for nonmetastatic osteosarcoma:Pediatric Oncology Group Study POG-8651[J].J Clin Oncol,2003,21(8):1574-1580. 被引量:1

共引文献45

同被引文献45

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部